Targeted limbic self-neuromodulation for alleviating central sensitization symptoms in fibromyalgia

Area of Science:

• Neuroscience
• Psychiatry
• Pain Management

Background:

• Fibromyalgia (FM) is a central sensitization syndrome with limited treatment options.
• Limbic system dysregulation plays a key role in FM's pain and affective symptoms.
• Understanding neural underpinnings enables novel neuromodulation strategies for FM.

Purpose of the Study:

• To assess the long-term efficacy of targeted limbic self-neuromodulation in fibromyalgia patients.
• To evaluate the impact of neurofeedback training on clinical disease burden and multidomain symptoms in FM.

Main Methods:

• A double-blind, randomized, dual-control study involving 47 FM patients.
• Interventions included genuine neurofeedback training (NFT), sham neurofeedback (NFS), and treatment as usual (TAU).
• Symptom Severity Score (SSS) and Fibromyalgia Impact Questionnaire (FIQ) assessed outcomes pre/post-treatment and at 10-12 month follow-up.

Main Results:

• NFT significantly reduced SSS and FIQ scores immediately and long-term.
• NFT demonstrated multidomain clinical benefits in FM patients.
• NFS showed long-term pain reduction, while TAU yielded no significant improvements.

Conclusions:

• Limbic brain areas are intimately involved in FM pathophysiology.
• Targeted neuromodulation is a promising, mechanism-based approach for managing FM symptoms.
• This study supports neurofeedback as a viable treatment for fibromyalgia.